ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

Medicare coverage and quality of care top ASCO’s list of policy priorities for 2004.

February 27, 2004

High Radiation Dose Effective Ten Years After Treatment

November 28, 2003

SSO Workshop Calls For Certification of Surgical Oncologists, Increased Commitments By NCI, ACS

November 18, 1983

Survival For ALL Increased To 94 Percent In Recent Years

December 31, 2010

Adjuvant Chemotherapy Unneeded In Children with Low-Risk Disease

March 29, 2013

Blayney Elected ASCO President For 2009.

March 7, 2008